Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future
The Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent prioritization, preclinical therapeutics testing, master protocol design and implementation, drug manufacturing and supply, data sharing, and public-private partnership value are shared to inform responses to future pandemics.
Authors
- Eric Hughes (ORCID: https://orcid.org/0000-0002-4590-6557)
- Stacey J. Adam (ORCID: https://orcid.org/0000-0002-4590-5175)
- Joshua P. Fessel (ORCID: https://orcid.org/0000-0003-0797-7693)
- Yves Rosenberg (ORCID: https://orcid.org/0000-0002-4131-1927)
- Lisa M. LaVange (ORCID: https://orcid.org/0000-0001-6755-6925)
- Timothy G. Buchman (ORCID: https://orcid.org/0000-0001-7350-5921)
- Joseph P. Menetski (ORCID: https://orcid.org/0000-0001-5657-1994)
- Ruxandra Draghia‐Akli (ORCID: https://orcid.org/0000-0001-6372-4039)
- Elizabeth S. Higgs
- Judith S. Currier (ORCID: https://orcid.org/0000-0003-4279-4737)
- ACHIEVE Collaborative Research Group
- Sarah W. Read (ORCID: https://orcid.org/0000-0003-3876-472X)
- Randall Tressler
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2024-11-05
- DOI
- https://doi.org/10.17615/6gp8-3k72
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00